Clinical Outcome and Future Liver Remnant Regenerative Response in Laparoscopic Versus Open ALPPS

Abroad (travel likely)RecruitingPHASE3

Conditions

Liver Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The University of Hong Kong, Hong Kong, Hong Kong
Contact: Study coordinator (Albert Chan) · acchan@hku.hk · +85222553025
Contact: Study coordinator (Crystal Kwan) · cryskal@hku.hk · +85222556646
Contact: Principal Investigator (Albert Chan)

Study leads

Albert Chan
Principal Investigator
The University of Hong Kong

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies

Liver Cancer (Primary and Metastatic) · Liver Ablation

Abroad (travel likely)Recruiting

Shanghai, China

Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.

Non Small Cell Lung Cancer · Breast Cancer · Colorectal Cancer

Abroad (travel likely)Recruiting

Ho Chi Minh City, Vietnam · Ho Chi Minh City, Vietnam

Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac

Rectal Cancer · Head and Neck Cancer · Liver Cancer

Abroad (travel likely)Recruiting

Tübingen, Germany

A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)

Advanced Liver Cancers · Tumor Infiltrating Lymphocyte · Treatment Side Effects

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China